|
 Customers
Pharmalef Developments is a drug discovery and development company, focusing on applications for new small molecule prescription drugs. The company conducts R&D projects and collaborates with many leading pharmaceutical, biotechnology and genomics companies, and is developing new chemistry technology for potential prescription drug applications.
Pharmalef Developments cooperates with accomplished scientists who have extensive experience within the pharmaceutical industry. Customers collaborate with us for a number of reasons, such as complementing existing resources, serving as a research and development department where none exists, accessing unique technologies and expertise, and many others. Pharmalef may be flexibly utilized for a wide variety of challenges encountered in pharmaceutical product research and development.
Contact Us
|
 |
 Corporate
News
 Pharmalef
Inc. is starting coloboration in development of new oral delivery platform
offers pharmaceutical companies the ability to extend the shelf life and
stability of medicinal compounds.
Moreover, oral delivery improves patient compliance, improves treatment, reduces
patient inconvenience, and reduces treatment costs.
Our partners have completed proof of concept and development of a proliposomal
formulation for the model drug, calcitonin, which is used in the treatment
of osteoporosis and thyroid cancer.
Clinical trials are expected to begin at a number of centers across the United
States, Canada and European Union.
|
 |
 |
